A Prescription Drug User Fee Act target date of May 27, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application ...
Seahorse XF RPMI Medium (Agilent Technologies) was supplemented with 2 mM L-glutamine (Agilent Technologies) for the Glycolysis Stress Test and with 10 mM glucose, 1 mM pyruvate and 2 mM L-glutamine ...
Background: Prostate cancer is the second most common cancer with a high risk of biochemical recurrence (BCR) among men. Recently, 5-methylcytosine (m5C) modification has attracted more attention as a ...
Could nanotechnology improve exercise performance? Evidence from animal studies Lima, M.R. Moreira, B.J. Bertuzzi, R. Lima-Silva, A.E.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback